Welcome to our dedicated page for Atomera SEC filings (Ticker: ATOM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Atomera Incorporated’s (NASDAQ: ATOM) SEC filings, offering a detailed view of how the semiconductor materials and technology licensing company reports its activities as a public issuer. Atomera’s filings include current reports on Form 8-K, annual and quarterly reports, and other documents that describe its Mears Silicon Technology™ (MST®), licensing-focused business model and risk profile.
Recent Form 8-K filings reference quarterly financial results and related investor presentations, as well as disclosures about Atomera’s use of its corporate website and LinkedIn account as channels for distributing material information under Regulation FD. These filings confirm that Atomera’s common stock, par value $0.001, trades on the Nasdaq Capital Market under the symbol ATOM, and they furnish press releases that discuss revenue levels, operating expenses, cash balances and non-GAAP metrics such as adjusted EBITDA.
Investors reviewing Atomera’s 10-K and 10-Q filings can examine risk factors, business descriptions and financial statements that elaborate on its status as an early-stage enterprise with minimal engineering services and licensing revenues to date. These reports typically cover topics such as joint development agreements, integration licenses, capital requirements and protection of proprietary MST technology, trade secrets and know-how.
Through this filings page, users can also monitor ongoing disclosure about collaborations and customer engagements, as many material announcements are cross-referenced in 8-Ks. Stock Titan’s tools surface Atomera’s latest submissions from the SEC’s EDGAR system and can pair them with AI-powered summaries that explain the key points in plain language, helping readers quickly understand the implications of lengthy 10-Ks, 10-Qs, 8-Ks and related exhibits, as well as track any future insider transaction reports on Form 4.
Atomera Incorporated has filed a preliminary proxy statement for its 2026 Annual Meeting of Stockholders to be held virtually on May 12, 2026. The meeting agenda includes: election of five directors, ratification of CBIZ CPAs P.C. as independent auditors, a proposal to increase authorized common stock to 95,000,000 shares, and a non-binding advisory vote on executive compensation.
The proxy materials state a record date of March 13, 2026 and report 38,722,969 shares outstanding as of that date. The board recommends votes FOR each management proposal. The proxy is being distributed beginning on or about March 31, 2026.
Atomera Inc reported that Chief Technology Officer Robert J. Mears received new performance-based stock option grants covering a total of 131,472 shares of common stock at an exercise price of $5.10 per share, expiring on March 11, 2036.
Each grant vests only if both time and stock price targets are achieved. The first 25% is scheduled to vest on March 1, 2027, with the remainder vesting in 12 equal quarterly installments. For each tranche, vesting also requires that the average volume-weighted stock price over any 30 consecutive trading days within five years of grant meets separate hurdles of $7.50, $12.50, or $20.00. If a given price threshold is not reached within five years, the related options will not vest and will terminate, and there were no open-market purchases or sales in this filing.
Atomera Inc CFO Laurencio Francis reported receiving three performance-based stock option grants on March 11, 2026. Each option has an exercise price of $5.10 and covers underlying shares of Atomera common stock in blocks of 78,888, 39,444 and 39,444 options.
The awards vest based on both time and share price performance. For each grant, 25% is scheduled to vest on March 1, 2027, with the remaining 75% vesting in 12 equal quarterly installments. However, vesting occurs only if the average volume-weighted share price over any 30 consecutive trading days within five years reaches specific thresholds of $7.50, $12.50, or $20.00, depending on the grant. If a grant’s price hurdle is not met within five years, none of its options vest and they terminate.
Atomera Inc CEO and President Scott A. Bibaud received three performance stock option grants covering a total of 341,840 shares of common stock at an exercise price of $5.10 per share. These options expire on March 11, 2036.
The awards vest only if both time- and performance-based conditions are met. For each grant, 25% is scheduled to vest on March 1, 2027, with the remaining 75% vesting in 12 equal quarterly installments thereafter, but only if the company’s average volume-weighted share price over any 30 consecutive trading days within five years from grant is at least $20.00, $12.50, or $7.50, depending on the specific tranche.
If the relevant stock price threshold for a tranche is not reached within five years from the grant date, none of the options in that tranche will vest and they will terminate at the end of that five-year period. These are compensation-related grants rather than open-market purchases.
Atomera Inc Chief Technology Officer Robert J. Mears reported both equity awards and related tax share sales in common stock. On March 2, 2026, he sold 3,979 shares at $4.95 per share in transactions described as mandatory "sell to cover" for tax withholding on vesting restricted stock.
On the same date, he was granted a total of 114,504 shares of common stock at no cost through restricted stock units and performance stock units. One restricted stock unit award vests 8.33% each quarter for 36 months starting June 1, 2026. The performance stock units vest on March 1, 2028 and March 1, 2029, respectively, if performance goals for periods from January 1, 2026 to December 31, 2027 and to December 31, 2028 are achieved. After these transactions, he directly owned 283,403 shares, with an additional 2,666 shares held indirectly by his spouse.
Atomera CFO Laurencio Francis reported multiple stock transactions in Atomera common stock. On March 2, 2026, he sold a total of 4,799 shares at $4.95 per share in open-market transactions.
According to the disclosure, these sales were made solely to cover tax withholding obligations arising from the vesting of previously granted restricted stock, under a mandatory, non-discretionary "sell to cover" arrangement pursuant to Rule 10b5-1(c)(1)(ii)(D)(3). On the same date, he also received several stock awards, including performance stock units and restricted stock units that each represent a right to receive one share of common stock, subject to future performance and time-based vesting conditions extending through March 2029.
Atomera Inc CEO and President Scott A. Bibaud reported a mix of equity awards and tax-related share sales. On March 2, 2026, he received several stock and performance-based stock unit grants at no cost, which will vest over multi‑year periods tied to performance and service. The same day, he sold 10,075 shares of common stock at $4.95 per share in open-market transactions to cover tax withholding obligations from previously vested restricted stock. After these transactions, his directly held common stock position was 709,741 shares.
Atomera Inc. notice of proposed sale of common stock by an insider. The filing lists 4,799 common shares tied to a vesting event on 03/01/2026 that were granted under the issuer's equity compensation plan, and records prior sales of 21,834 common shares on 02/20/2026 for $158,301.78.
ATOM filed a Form 144 reporting an intended sale of 3,979 common shares associated with the vesting of restricted stock granted under the issuer's equity compensation plan. The vesting event is dated 03/01/2026 and the filing is dated 03/02/2026. The transaction lists Morgan Stanley Smith Barney LLC as the broker and indicates NASDAQ as the market.
Morgan Stanley Smith Barney LLC Executive Financial Services reported the vesting of 10,075 shares of Common stock under the issuer's equity compensation plan with dates shown 03/01/2026 and 03/02/2026.
The filing lists this vesting alongside a Form 144 securities‑to‑be‑sold entry for Common stock on 03/02/2026; the shares were granted as part of the issuer's equity compensation plan.